Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | VEGFA | P15692 | 3/20 | 0.68 |
| ▸ | PGF | P49763 | 3/20 | 0.68 |
| ▸ | FLT1 | P17948 | 2/20 | 0.68 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.51 |
| ▸ | SNCA | P37840 | 3/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.49 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.49 |
| ▸ | MMP2 | P08253 | 4/20 | 0.48 |
| ▸ | MMP9 | P14780 | 4/20 | 0.48 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.48 |
| ▸ | PRKCG | P05129 | 1/20 | 0.48 |
| ▸ | PRKCB | P05771 | 1/20 | 0.48 |
| ▸ | PRKCA | P17252 | 1/20 | 0.48 |
| ▸ | PRKCH | P24723 | 1/20 | 0.48 |
| ▸ | PRKCI | P41743 | 1/20 | 0.48 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.48 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.48 |
| ▸ | PRKCZ | Q05513 | 1/20 | 0.48 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27426284 | 0.92 | VEGFA (0.71) | VEGFAPGFFLT1PTGS1SNCA | |
| SCHEMBL27426382 | 0.92 | VEGFA (0.71) | VEGFAPGFFLT1PTGS1SNCA | |
| SCHEMBL27426404 | 0.92 | VEGFA (0.71) | VEGFAPGFFLT1PTGS1SNCA | |
| SCHEMBL27426399 | 0.89 | VEGFA (0.67) | VEGFAPGFFLT1PTGS1SNCA | |
| SCHEMBL27426275 | 0.89 | VEGFA (0.67) | VEGFAPGFFLT1PTGS1SNCA | |
| SCHEMBL27426290 | 0.89 | VEGFA (0.67) | VEGFAPGFFLT1PTGS1SNCA | |
| SCHEMBL27426577 | 0.89 | VEGFA (0.67) | VEGFAPGFFLT1PTGS1SNCA | |
| SCHEMBL27426375 | 0.89 | VEGFA (0.67) | VEGFAPGFFLT1PTGS1SNCA | |
| SCHEMBL18293074 | 0.78 | VEGFA (0.81) | VEGFAPGFFLT1PTGS1SNCA | |
| SCHEMBL25736035 | 0.73 | SNCA (0.89) | VEGFAPGFPTGS1SNCAHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240216458-A1 | Composition for the prevention, improvement or treatment of allergic diseases comprising an extract of Cassia mimosoides L. as an active ingredient | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2024-07-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240216458-A1 | Composition for the prevention, improvement or treatment of allergic diseases comprising an extract of Cassia mimosoides L. as an active ingredient | CMA1, HRH4, CCL11 | VEGFA 2250/4885PGF 3791/4885FLT1 2692/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.